Haroutunian V - Search Results

1

White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. Davis KL, et al. Among authors: haroutunian v. Arch Gen Psychiatry. 2003 May;60(5):443-56. doi: 10.1001/archpsyc.60.5.443. Arch Gen Psychiatry. 2003. PMID: 12742865 Review.

2

Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert.

Wallace WC, Bragin V, Robakis NK, Sambamurti K, VanderPutten D, Merril CR, Davis KL, Santucci AC, Haroutunian V. Wallace WC, et al. Among authors: haroutunian v. Brain Res Mol Brain Res. 1991 May;10(2):173-8. doi: 10.1016/0169-328x(91)90108-a. Brain Res Mol Brain Res. 1991. PMID: 1649369

3

Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats.

Santucci AC, Haroutunian V, Davis KL. Santucci AC, et al. Among authors: haroutunian v. Clin Neuropharmacol. 1991;14 Suppl 1:S1-8. doi: 10.1097/00002826-199114001-00002. Clin Neuropharmacol. 1991. PMID: 1913705

4

Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.

Haroutunian V, Santucci AC, Davis KL. Haroutunian V, et al. Prog Brain Res. 1990;84:333-46. doi: 10.1016/s0079-6123(08)60917-6. Prog Brain Res. 1990. PMID: 1980019 No abstract available.

5

Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats.

Haroutunian V, Kanof PD, Tsuboyama G, Davis KL. Haroutunian V, et al. Brain Res. 1990 Jan 22;507(2):261-6. doi: 10.1016/0006-8993(90)90280-o. Brain Res. 1990. PMID: 2110845

6

Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.

Santucci AC, Haroutunian V, Tsuboyama GK, Kanof PD, Davis KL. Santucci AC, et al. Among authors: haroutunian v. Prog Clin Biol Res. 1989;317:1111-20. Prog Clin Biol Res. 1989. PMID: 2690088 Review. No abstract available.

7

Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factor.

Haroutunian V, Kanof PD, Davis KL. Haroutunian V, et al. Brain Res. 1989 May 15;487(1):200-3. doi: 10.1016/0006-8993(89)90960-8. Brain Res. 1989. PMID: 2752286

8

Interactions of forebrain cholinergic and somatostatinergic systems in the rat.

Haroutunian V, Kanof PD, Davis KL. Haroutunian V, et al. Brain Res. 1989 Sep 4;496(1-2):98-104. doi: 10.1016/0006-8993(89)91055-x. Brain Res. 1989. PMID: 2804656

9

Cholinergic modulation of memory in rats.

Haroutunian V, Barnes E, Davis KL. Haroutunian V, et al. Psychopharmacology (Berl). 1985;87(3):266-71. doi: 10.1007/BF00432705. Psychopharmacology (Berl). 1985. PMID: 3001803

10

Effects of mesocortical dopaminergic lesions upon subcortical dopaminergic function.

Haroutunian V, Knott P, Davis KL. Haroutunian V, et al. Psychopharmacol Bull. 1988;24(3):341-4. Psychopharmacol Bull. 1988. PMID: 3153491 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters